Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity
Zhang, L.; Chinnam, M.; Balk, B.; Zhang, X.; Wang, Y.; Shaurova, T.; Alam, S.; Pokharel, S.; Singh, P.; Jacobi, J.; Wang, J.; Cortes Gomez, E.; Habitzruther, M.; Seshadri, M.; Atanassov, B.; Wu, W.; Benevolenskaya, E.; Blakely, C. M.; Hershberger, P.; Long, M.; Bivona, T.; Goodrich, D. W.
Show abstract
Treatment with EGFR tyrosine kinase inhibitors (EGFR TKI) is standard of care for patients with lung cancer initiated by activating mutations in the EGFR gene. While EGFR TKI treatment is effective, virtually all patients progress on therapy. Loss of function mutations in the RB1 tumor suppressor gene are associated with poor EGFR TKI outcomes, but underlying mechanisms remain unclear. Analysis of genetically engineered experimental models and human clinical specimens described here demonstrates RB1 loss has minimal impact on initial cell cycle responses to EGFR TKI but markedly accelerates acquired resistance over time. RB1 loss promotes transcriptional plasticity that enables rare cells to spontaneously assume reversible, resistance-conferring lineage states. These findings highlight the importance of non-genetic adaptations in driving acquired EGFR TKI resistance, advance our understanding of how RB1 impacts cancer, and identify opportunities to improve EGFR TKI treatment outcomes by targeting reversible epigenetic resistance mechanisms.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 98%
- A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer 97%
- Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures 97%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Regulation of lung cancer initiation and progression by the stem cell determinant Musashi 96%
- Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer 96%
- Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. 96%
Similar papers in this journal
- Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state 96%
- Interrogation of cancer gene dependencies reveals novel paralog interactions of autosome and sexchromosome encoded genes 96%
- Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.